{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-006815","form_type":"8-K","ticker":"PVCT","cik":"0000315545","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","filed_at":"2024-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.545764+00:00","generated_at":"2026-06-06T01:38:20.206926+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Provectus Biopharmaceuticals to host conference call on Feb 22, 2024 for company updates","bullets":["Conference call scheduled for February 22, 2024 at 3:00 p.m. EST to discuss company updates.","Dial-in: 1-800-319-4610 (US) or 1-604-638-5340 (international); advance registration available.","No financial results or specific material events disclosed in the press release."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-006815","json":"https://secwatch.observer/filing/0001493152-24-006815.json","markdown":"https://secwatch.observer/filing/0001493152-24-006815.md","text":"https://secwatch.observer/filing/0001493152-24-006815.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/315545/000149315224006815/0001493152-24-006815-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/315545/000149315224006815/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T01:38:20.206926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}